U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 204015

Expand all

FOSAPREPITANT DIMEGLUMINE (FOSAPREPITANT DIMEGLUMINE)
EQ 150MG BASE/VIAL
Marketing Status: Prescription
Active Ingredient: FOSAPREPITANT DIMEGLUMINE
Proprietary Name: FOSAPREPITANT DIMEGLUMINE
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 150MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A204015
Product Number: 002
Approval Date: Sep 5, 2019
Applicant Holder Full Name: MYLAN LABORATORIES LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
FOSAPREPITANT DIMEGLUMINE (FOSAPREPITANT DIMEGLUMINE)
EQ 115MG BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: FOSAPREPITANT DIMEGLUMINE
Proprietary Name: FOSAPREPITANT DIMEGLUMINE
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 115MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A204015
Product Number: 001
Approval Date: Sep 5, 2019
Applicant Holder Full Name: MYLAN LABORATORIES LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top